• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer.低表达 DUSP4 与胃癌侵袭性表型和不良预后相关。
In Vivo. 2021 Jan-Feb;35(1):131-140. doi: 10.21873/invivo.12240.
2
Low expression of DUSP4 expression predicts unfavorable prognosis in gallbladder adenocarcinoma.DUSP4 表达水平低预示胆囊腺癌预后不良。
Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):809-813. doi: 10.4103/ijpm.ijpm_352_21.
3
MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.miR-122-5p 通过下调 DUSP4 抑制胃癌细胞迁移和侵袭。
Cancer Biol Ther. 2018 May 4;19(5):427-435. doi: 10.1080/15384047.2018.1423925. Epub 2018 Mar 6.
4
Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.血根碱通过调节双特异性磷酸酶4/细胞外信号调节激酶(DUSP4/ERK)通路抑制胃癌细胞的生长和侵袭。
J Cell Mol Med. 2017 Jun;21(6):1117-1127. doi: 10.1111/jcmm.13043. Epub 2016 Dec 13.
5
Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.DUSP4 表达降低与结直肠癌肝肺转移相关。
Med Oncol. 2013;30(3):620. doi: 10.1007/s12032-013-0620-x. Epub 2013 Jun 8.
6
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.雌激素受体阴性乳腺癌中磷酸酶的分析确定双特异性磷酸酶4是生长和侵袭的关键调节因子。
Breast Cancer Res Treat. 2016 Aug;158(3):441-54. doi: 10.1007/s10549-016-3892-y. Epub 2016 Jul 8.
7
Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.MAP 激酶磷酸酶 DUSP4 的表达与结直肠癌(CRC)中的微卫星不稳定性相关,并导致细胞增殖增加。
Int J Cancer. 2013 Apr 1;132(7):1537-46. doi: 10.1002/ijc.27834. Epub 2012 Nov 23.
8
Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.由于 DUSP4 的缺失导致 MAPK 通路的激活促进了基底样乳腺癌中癌症干细胞样表型的出现。
Cancer Res. 2013 Oct 15;73(20):6346-58. doi: 10.1158/0008-5472.CAN-13-1385. Epub 2013 Aug 21.
9
Patterns of Dual-Specific Phosphatase 4 mRNA Expression Before and after Neoadjuvant Chemotherapy in Breast Cancer.乳腺癌新辅助化疗前后双特异性磷酸酶4 mRNA表达模式
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1051-1055. doi: 10.31557/APJCP.2019.20.4.1051.
10
Lysine-Specific Histone Demethylase 1 Promotes Oncogenesis of the Esophageal Squamous Cell Carcinoma by Upregulating DUSP4.赖氨酸特异性组蛋白去甲基酶 1 通过上调 DUSP4 促进食管鳞癌的发生。
Biochemistry (Mosc). 2021 Dec;86(12):1624-1634. doi: 10.1134/S0006297921120117.

引用本文的文献

1
FENDRR Affects COAD Biological Behavior by Inhibiting the DUSP4/CREB/PRKACB Pathway.FENDRR通过抑制DUSP4/CREB/PRKACB信号通路影响结肠癌的生物学行为。
Int J Genomics. 2025 Jul 1;2025:2765511. doi: 10.1155/ijog/2765511. eCollection 2025.
2
siRNA-based strategies to combat drug resistance in gastric cancer.基于 siRNA 的策略来对抗胃癌的耐药性。
Med Oncol. 2024 Oct 21;41(11):293. doi: 10.1007/s12032-024-02528-w.
3
ARID1A loss activates MAPK signaling via DUSP4 downregulation.ARID1A 缺失通过下调 DUSP4 激活 MAPK 信号通路。
J Biomed Sci. 2023 Dec 9;30(1):94. doi: 10.1186/s12929-023-00985-5.
4
ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis.基于单细胞RNA测序分析,ASCL2影响结肠腺癌免疫治疗的疗效。
Front Immunol. 2022 Jun 3;13:829640. doi: 10.3389/fimmu.2022.829640. eCollection 2022.
5
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance.双特异性磷酸酶:癌症治疗耐药性中的治疗靶点。
J Cancer Res Clin Oncol. 2022 Jan;148(1):57-70. doi: 10.1007/s00432-021-03874-2. Epub 2022 Jan 4.

本文引用的文献

1
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.全球、地区和国家 195 个国家/地区 1990-2017 年胃癌负担:2017 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):42-54. doi: 10.1016/S2468-1253(19)30328-0. Epub 2019 Oct 21.
2
Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.转移性胃癌的靶向治疗:当前的认识和未来的展望。
World J Gastroenterol. 2019 Oct 14;25(38):5773-5788. doi: 10.3748/wjg.v25.i38.5773.
3
Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes.通过解读可靶向致癌基因的突变状态和表达来揭示结直肠癌潜在的治疗靶点
Cancers (Basel). 2019 Jul 14;11(7):983. doi: 10.3390/cancers11070983.
4
Dual-specificity MAP kinase phosphatases in health and disease.双特异性丝裂原活化蛋白激酶磷酸酶在健康和疾病中的作用。
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):124-143. doi: 10.1016/j.bbamcr.2018.09.002. Epub 2018 Sep 8.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.miR-122-5p 通过下调 DUSP4 抑制胃癌细胞迁移和侵袭。
Cancer Biol Ther. 2018 May 4;19(5):427-435. doi: 10.1080/15384047.2018.1423925. Epub 2018 Mar 6.
7
DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition.双特异性磷酸酶4通过上皮-间质转化促进胃癌对阿霉素的耐药性。
Oncotarget. 2017 Oct 4;8(55):94028-94039. doi: 10.18632/oncotarget.21522. eCollection 2017 Nov 7.
8
Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.双特异性磷酸酶4的下调增强了结直肠癌的细胞增殖和侵袭能力。
Cancer Sci. 2018 Jan;109(1):250-258. doi: 10.1111/cas.13444. Epub 2017 Dec 8.
9
IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition.IL4 通过抑制 DUSP4 来启动乳腺癌进展的动力学。
Cancer Res. 2017 Jun 15;77(12):3268-3279. doi: 10.1158/0008-5472.CAN-16-3126. Epub 2017 Apr 11.
10
Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway.血根碱通过调节双特异性磷酸酶4/细胞外信号调节激酶(DUSP4/ERK)通路抑制胃癌细胞的生长和侵袭。
J Cell Mol Med. 2017 Jun;21(6):1117-1127. doi: 10.1111/jcmm.13043. Epub 2016 Dec 13.

低表达 DUSP4 与胃癌侵袭性表型和不良预后相关。

Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer.

机构信息

Department of Pathology, Seoul Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea.

Department of Surgery, Seoul Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea.

出版信息

In Vivo. 2021 Jan-Feb;35(1):131-140. doi: 10.21873/invivo.12240.

DOI:10.21873/invivo.12240
PMID:33402458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7880801/
Abstract

BACKGROUND/AIM: Dual-specificity protein phosphatase 4 (DUSP4) negatively regulates MAPK signaling and is involved in various cellular processes. We herein evaluated the relationship between DUSP4 expression and clinicopathological characteristics in a large series of gastric cancer samples.

MATERIALS AND METHODS

DUSP4 expression was examined by immunohistochemistry in 508 gastric cancer samples. Cases were classified according to the TCGA molecular classification and HER2 amplification. Kaplan-Meier plots were used to predict the relationship between mRNA expression of DUSP4 and survival.

RESULTS

Low expression of DUSP4 was significantly correlated with larger tumor size, higher pT category, positive nodal status, higher stage, lymphovascular invasion, perineural invasion, worse overall survival, and worse recurrence-free survival. No correlation was observed between DUSP4 expression and molecular characteristics. Bioinformatics analysis showed that low mRNA expression was associated with a poor prognosis.

CONCLUSION

Low expression of DUSP4 is associated with aggressive phenotypes of gastric cancer and a poor prognosis.

摘要

背景/目的:双特异性蛋白磷酸酶 4(DUSP4)负调控 MAPK 信号转导,并参与多种细胞过程。本研究旨在评估 DUSP4 表达与大型胃癌样本临床病理特征之间的关系。

材料与方法

采用免疫组织化学法检测 508 例胃癌组织中 DUSP4 的表达。根据 TCGA 分子分类和 HER2 扩增情况对病例进行分类。Kaplan-Meier 图用于预测 DUSP4 mRNA 表达与生存之间的关系。

结果

DUSP4 低表达与肿瘤体积较大、pT 分期较高、淋巴结阳性、分期较高、淋巴管浸润、神经周围浸润、总生存期较差和无复发生存期较差显著相关。DUSP4 表达与分子特征之间无相关性。生物信息学分析显示,低 mRNA 表达与胃癌不良预后相关。

结论

DUSP4 低表达与胃癌侵袭性表型和不良预后相关。